Top Companies in China Hydroxyzine Market | Key Players & Insights 2026

Top Companies in China Hydroxyzine Market

China hydroxyzine market is characterized by a strong presence of large-scale integrated pharmaceutical groups and specialized active pharmaceutical ingredient (API) manufacturers that maintain dominance through extensive manufacturing capacity. Leading companies in the market include Shanghai Pharmaceuticals Holding Co., Ltd., China Resources Pharmaceutical Group, Jiangsu Hengrui Pharmaceuticals Co., Ltd., and Humanwell Healthcare (Group) Co., Ltd.

China Hydroxyzine Market Overview

According to 6Wresearch, the China hydroxyzine market is expected to increase significantly, fueled by the rising prevalence of allergic diseases and a shift toward non-benzodiazepine anxiolytics in an aging demographic. The industry is significantly driven by the adoption of generic formulations and a growing population prone to chronic dermatological conditions such as urticaria and histamine-mediated pruritus.

Furthermore, the incorporation of advanced oral delivery systems has become a standard for large enterprises in Hubei and Jiangsu, as they seek to enhance bioavailability and therapeutic outcomes using sophisticated chemical synthesis and purification techniques.

Competitive Landscape

The competitive landscape of the China hydroxyzine market is characterized by high-intensity competition between specialized active pharmaceutical ingredient (API) manufacturers and well-established domestic generic leaders. By offering a variety of dosage forms, such as tablets, capsules, and oral solutions, leading companies maintain a dominant market share. Additionally, the market sees frequent collaborations between research-led firms and third-party manufacturers to scale production and meet the rising domestic demand for cost-effective antihistamine and sedative treatments.

Below is a list of key players operating in the China Hydroxyzine Market:

1. Shanghai Pharmaceuticals Holding Co., Ltd.

A vertically integrated pharmaceutical leader covering R&D, manufacturing, and distribution of a wide range of generic and innovative drugs.

2. China Resources Pharmaceutical Group

A leading integrated pharmaceutical company in China engaged in the research, development, and manufacturing of a broad range of pharmaceutical products.

3. Jiangsu Hengrui Pharmaceuticals Co., Ltd.

China's leading innovation-driven pharmaceutical giant with a robust portfolio in oncology and central nervous system (CNS) therapies.

4. Humanwell Healthcare (Group) Co., Ltd.

A market leader in anesthetics and analgesics, with an expanding portfolio in treating CNS, respiratory, and dermatological diseases.

5. CSPC Pharmaceutical Group Limited

A major integrated group that leads the market in finished-dosage medications and bulk drug production for cardiovascular and CNS segments.

6. Sino Biopharmaceutical Limited

A leading innovative pharmaceutical group in China, focusing on hepatitis, oncology, and respiratory system diseases.

7. Huadong Medicine Co., Ltd.

A prominent player in the East China region, known for its expertise in immunosuppressants and a growing neuro-psychiatry segment.

8. Zhejiang Huahai Pharmaceutical Co., Ltd.

A global powerhouse in finished-dosage generics and APIs, maintaining high-standard facilities for neurological medications.

9. Yunnan Baiyao Group

A major player in traditional and modern medicine, expanding its international footprint in the pharmaceutical and healthcare sectors.

10. Harbin Pharmaceutical Group Co., Ltd.

A competitive pharmaceutical entity that invests heavily in R&D to expand its domestic manufacturing and export capabilities.

11. Hansoh Pharmaceutical Group

Focuses on innovative drugs and high-end generics in oncology, CNS, and anti-infectives.

12. Wuxi AppTec (WuXi PharmaTech)

A global CRDMO leader providing advanced intermediate and API manufacturing services to the pharmaceutical industry.

13. Sandoo Pharmaceuticals and Chemicals Co., Ltd.

A technologically innovative manufacturer of hydroxyzine intermediates and advanced building blocks.

14. Changzhou ComWin Fine Chemicals Co., Ltd.

A major manufacturer focusing on fine chemicals and intermediates for the domestic CNS medication market.

15. Hong Kong Dengyue Pharmaceutical Limited

A pharmaceutical export wholesaler specializing in Chinese innovative medicines and providing high-quality global supply solutions.

Top Companies in China Hydroxyzine Market: FAQs